Travel Time to Treating Facility and Mortality in Men With Prostate Cancer
This cohort study found that longer travel time to treatment facilities was associated with lower all-cause and prostate cancer-specific mortality, possibly reflecting better quality through care centralization at specialized centers. While consistent across most subgroups, the findings should be interpreted with consideration of access barriers, such as transportation, that may contribute to missed or delayed diagnoses.
Authors
- Alexander P. Cole
- Zhiyu Qian
- Stephan Korn
- Brenda Y. Hernandez (ORCID: https://orcid.org/0000-0003-0132-4042)
- Mei‐Chin Hsieh (ORCID: https://orcid.org/0000-0001-7842-1225)
- Hanna Zurl
- Joel S. Weissman (ORCID: https://orcid.org/0000-0002-4990-6263)
- Amanda J. Reich (ORCID: https://orcid.org/0000-0001-5922-4154)
- Quoc‐Dien Trinh (ORCID: https://orcid.org/0000-0003-3857-9276)
- Hari S. Iyer (ORCID: https://orcid.org/0000-0002-7596-9049)
- Danesha Daniels
- Andrea Piccolini (ORCID: https://orcid.org/0009-0004-6601-1244)
- Filippo Dagnino
- Klara Pohl (ORCID: https://orcid.org/0009-0001-6740-4005)
Institutions
- Rutgers, The State University of New Jersey (US)
- Louisiana State Department of Health and Hospitals (US)
- Brigham and Women's Hospital (US)
- Humanitas University (IT)
- Harvard University (US)
- University of Pittsburgh (US)
- Medical University of Graz (AT)
- Cancer Center of Hawaii (US)
- IRCCS Humanitas Research Hospital (IT)
- Louisiana State University Health Sciences Center New Orleans (US)
- Medical University of Vienna (AT)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2025-12-03
- DOI
- https://doi.org/10.1001/jamanetworkopen.2025.46812
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- U.S. Department of Defense
- Cancer Research UK
- Centers for Disease Control and Prevention
- National Cancer Institute